{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T04:09:31Z","timestamp":1749614971463,"version":"3.41.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.reumae.2025.501851","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T13:09:37Z","timestamp":1749560977000},"page":"501851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mean corpuscular volume and red cell distribution width as predictors of methotrexate response in RA patients"],"prefix":"10.1016","volume":"21","author":[{"given":"Benitez Cristian","family":"Alejandro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gomez Ramiro","family":"Adri\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pe\u00f3n","family":"Claudia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfaro Mar\u00eda","family":"Agustina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Andrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klimovsky","family":"Ezequiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamba Mar\u00eda","family":"Julieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2025.501851_bib0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jbspin.2012.02.005","article-title":"Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis","volume":"80","author":"Dadoun","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.reumae.2025.501851_bib0115","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.reumae.2025.501851_bib0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/annrheumdis-2015-209057","article-title":"Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-na\u00efve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study","volume":"76","author":"Emery","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2025.501851_bib0210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrrheum.2010.5","article-title":"Methotrexate \u2013 how does it really work?","volume":"6","author":"Chan","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.reumae.2025.501851_bib0125","doi-asserted-by":"crossref","first-page":"102405","DOI":"10.1016\/j.jaut.2020.102405","article-title":"Precision medicine and management of rheumatoid arthritis","volume":"110","author":"Aletaha","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.reumae.2025.501851_bib0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10067-017-3871-7","article-title":"Red blood cell distribution width: a potential laboratory parameter for monitoring inflammation in rheumatoid arthritis","volume":"37","author":"He","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2025.501851_bib0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4081\/reumatismo.2020.1243","article-title":"Association between red cell distribution width and response to methotrexate in rheumatoid arthritis","volume":"72","author":"Bellan","year":"2020","journal-title":"Reumatismo"},{"key":"10.1016\/j.reumae.2025.501851_bib0170","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3233\/CH-131738","article-title":"RDW in patients with systemic lupus erythematosus. Influence of anaemia and inflammatory markers","volume":"54","author":"Vay\u00e1","year":"2013","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.reumae.2025.501851_bib0175","doi-asserted-by":"crossref","first-page":"E1779","DOI":"10.1016\/S0735-1097(12)61780-X","article-title":"Association between red cell distribution width (Rdw), inflammatory markers and cardiovascular fitness in healthy adults: data from National Health and Nutrition Examination Survey 1999\u20132004","volume":"59","author":"Agarwal","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.reumae.2025.501851_bib0180","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.cca.2011.07.018","article-title":"Red cell distribution width C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population","volume":"412","author":"Lapp\u00e9","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.reumae.2025.501851_bib0185","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s10620-007-0176-8","article-title":"RDW as an additional marker in inflammatory bowel disease\/undifferentiated colitis","volume":"53","author":"Clarke","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.reumae.2025.501851_bib0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.archger.2012.10.002","article-title":"Is increased red cell distribution width (RDW) indicating the inflammation in Alzheimer's disease (AD)?","volume":"56","author":"\u00d6zt\u00fcrk","year":"2013","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.reumae.2025.501851_bib0195","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/gerona\/glp163","article-title":"Red cell distribution width and mortality in older adults: a meta-analysis","volume":"65","author":"Patel","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.reumae.2025.501851_bib0205","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/rheumatology\/keab403","article-title":"The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume","volume":"61","author":"Shipa","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.reumae.2025.501851_bib0215","article-title":"An increase in red cell mean corpuscular volume by methotrexate is potentiated by hydroxychloroquine and predicts clinical response in rheumatoid arthritis","volume":"72","author":"Shipa","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2025.501851_bib0220","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2025.501851_bib0225","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/ard.49.11.916","article-title":"Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score","volume":"49","author":"van der Heijde","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2025.501851_bib0230","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.501851_bib0235","doi-asserted-by":"crossref","first-page":"R796","DOI":"10.1186\/ar1740","article-title":"Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score","volume":"7","author":"Aletaha","year":"2005","journal-title":"Arthritis Res Ther"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574325000504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574325000504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T13:38:51Z","timestamp":1749562731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574325000504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2173574325000504"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2025.501851","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mean corpuscular volume and red cell distribution width as predictors of methotrexate response in RA patients","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2025.501851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2025.501851","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Reumatolog\u00eda (SER), Colegio Mexicano de Reumatolog\u00eda (CMR) and Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501851"}}